1 / 7

Pulmonary Drug Delivery Systems Market

Global Pulmonary Drug Delivery Systems Market is expected to grow at CAGR of 6.2% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Pulmonary Drug Delivery

jayashripatil
Download Presentation

Pulmonary Drug Delivery Systems Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pulmonary Drug Delivery Systems Market2017 – 2025 Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  2. Global Pulmonary Drug Delivery Market is Estimated to Reach $52.9 Billion by 2025 • Global pulmonary drug delivery market report published by Accurize Market Research forecast that the global market is expected to reach $52.9 billion by 2025; growing at a CAGR of 6.6% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period. • Request Sample:  https://www.accurizemarketresearch.com/report/pulmonary-drug-delivery-systems-market/sample-request Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  3. Global Pulmonary Drug Delivery Market is Estimated to Reach $52.9 Billion by 2025 • Technological developments in the field of drug delivery and growing demand for new products, changing lifestyle, ease of use and improved facilities across the globe to drive the growth of the market • Technological developments in the field of drug delivery and growing demand for new products, changing lifestyle, ease of use and improved facilities fuels the demand for the global pulmonary drug delivery market. Moreover, the upsurge in the number of public and private organizations also boosts the growth of the market. Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  4. Market Segmentation • The global pulmonary drug delivery market has been bifurcated on the basis of product, application, and geography. On the basis of the product, it is divided into metered-dose inhalers (breath-actuated pressurized inhaler and manually-actuated pressurized inhaler), nebulizers (jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers), and dry powder inhalers (single dose inhalers and multi-dose inhalers). • On the basis of the distributor segment, it is bifurcated into Retail Pharmacies, Hospital Pharmacies, and E-commerce. On the basis of application, the market is segmented into asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), and others. • Request Customization: https://www.accurizemarketresearch.com/report/pulmonary-drug-delivery-systems-market/ask-for-customization Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  5. Market Segmentation • By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers the UK, Germany, France, Italy, and others. Asia-Pacific covers China, India, Japan, South Korea, and others. The rest of the World covers South America, the Middle East, and Africa. • “North America dominated the pulmonary drug delivery devices market during the forecast period”, says accurize • In 2017, North America dominated the pulmonary drug delivery devices market and Asia accounted for the second-largest regional market. Moreover, the Asia-Pacific is expected to register the highest CAGR during the forecast period due to the rapid growth of the geriatric population, growing acceptance of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals and the successive increase in the prevalence of COPD in the area Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  6. Top players in the market The key market players include • GlaxoSmithKline plc • Novartis AG • Koninklijke Philips N.V. • 3M Company • Actelion Pharmaceuticals Ltd • AstraZeneca plc • BoehringerIngelheimGmbh • Clement Clarke International • Briggs Healthcare • Aerogenamong others Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

  7. Contact Us: Accurize Market Research Pvt. Ltd. PUNE OFFICE: 306, ZEN BUSINESS CENTER, WAKAD, NEAR BHUMKAR CHOWK, MUMBAI BANGALORE HIGHWAY, PUNE-411057 Email: help@accurizemarketresearch.com Contact No: +1-339-368-6383 Copyright © 2019 Accurize Market Research sales@accurizemarketresearch.com

More Related